The first generic version of Symbicort -- a metered-dose inhaler that combines the corticosteroid budesonide with the long-acting bronchodilator formoterol -- has been approved for asthma and ...

The new inhaler replaces Trixeo Aerosphere’s existing gas propellant with a low global warming-potential alternative.

Millions of asthma, chronic bronchitis and emphysema sufferers can now begin ordering a Raleigh-based firm's new breath-activated devices for inhalers that are designed to improve drug delivery.

Chronic bronchitis is another possibility, though 2020 research suggests chronic cough is rare in children. It produces similar symptoms, but they may last much longer, usually beyond 4 weeks.

TRENTON, N.J. (AP) — The Food and Drug Administration has approved the first inhaler combining three medicines to ease breathing in patients with emphysema or chronic bronchitis. The FDA late ...

Final trials are underway at Temple Health for RheOx, a minimally invasive treatment for chronic bronchitis. It's aimed at reducing mucus that clogs airways, and hampers breathing.

UNDATED (AP) — The Food and Drug Administration has approved the first inhaler that combines three medicines to ease breathing in patients with emphysema or chronic bronchitis. GlaxoSmithKline ...

Eosinophilic bronchitis is a rare for of bronchitis that doesn't cause breathing difficulties. Keep reading to learn the symptoms, treatment, and suspected causes: ...

TRENTON, N.J. (AP) - The Food and Drug Administration has approved the first inhaler combining three medicines to ease breathing in patients with emphysema or chronic bronchitis. The FDA late ...